Pros
-Tons of learning opportunities for all skills in all areas -Great leadership who led the company through tricky times -Went public with one phase I asset, had lots of hype around the technology/portfolio -Location away from craziness of Cambridge/Kendall, great for those who drive to work
Cons
-Highly unlikely Selecta will ever launch a product. I can’t elaborate on why I believe this though -Shift in focus over the years is a symptom of a biotech which has struggled to define itself after major failures -90%+ stock price dip from IPO and fleeing institutional investors hamper ability to acquire funding -Major issues uncovered which never should have been issues to begin with, some of which were egregious -Location isn’t great for public transit users